You guys do realize our drug only works on 87% the other 13% has a mutated genes but anp works on the other 87% So still very big.
But for nuisance Asthma, Spms, etc it has to be tested.
our dmd drug is for dmd, atm so for other diseases you have to have a trail for them to see if it works on them.
you can't use a dmd drug on someone that has asthma with trials testing. Yes it could be use for them.
But like with cancer not all cancer are the same n not one drug will work the sam
So our dmd drug not work the same for asthma n needs to be tricked or might not work at all.
atm atl1102 is for dmd n it's working. so for others it needs to be tested. So hopefully if they can process to production. phase 1 n 2 trails would cost nothing because the money from dmd would cover it.
But good to see it's above 10c wounder if they still stucking people in or if the ran out of shares.
6.6m is alot for today
- Forums
- ASX - By Stock
- PER
- Sarepta eyes multiple sclerosis gene therapy
Sarepta eyes multiple sclerosis gene therapy, page-41
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.001(0.63%) |
Mkt cap ! $73.02M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 7.8¢ | $49.82K | 622.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18350 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 18443 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 118350 | 0.080 |
1 | 46478 | 0.079 |
2 | 185715 | 0.078 |
2 | 207500 | 0.077 |
3 | 84700 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 18455 | 1 |
0.082 | 280358 | 3 |
0.083 | 117277 | 2 |
0.084 | 157142 | 2 |
0.085 | 553000 | 3 |
Last trade - 14.05pm 17/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |